/ Print /

Benefit design and pricing

Three ways payers can help consumers make wise healthcare decisionsPayers can facilitate action on the part of physicians to appreciate the growing awareness and financial responsibility of their patients and to better use a shared decision-making approach. Here’s three ways how.
Opinion: Who's to blame for surprise out-of-network bills?Across the country more states are taking steps to limit patients’ exposure to surprise out-of-network bills.
Top 3 factors in biosimilar coverageAn Avalere study has interesting findings about payer acceptance of biosimilars.
Four things to watch in Senate Obamacare replacementHealthcare analysts offer four things MCOs should know about the Better Care Reconciliation Act or BCRA.
Why there’s an uptick in outcomes-based contractsOperational issues aside, outcomes-based contracts can offer a two-fold benefit for managed care executives.
Top 3 strategies employers should use to decrease healthcare costsA new Willis Towers Watson survey finds that U.S. employers have three key strategies to building cost-effective healthcare programs. 
What's missing in hep C drugsPayers have unmet needs in the changing hepatitis C (HCV) space, according to a recent survey. The survey, from Precision for Value, highlights what can be done to encourage payers to ease coverage policies for these drugs in the next wave of HCV treatment.
Opinion: Substance use disorder privacy law limits both payers, prescribersTwo University of Massachusetts Medical School pharmacists make the case to reform or align 42 CFR Part 2 with HIPAA to better serve patients with substance use disorder.
Partnership aims to make insulin more affordableCVS, Novo Nordisk launch a prescription savings program to help patients afford essential medications.
Insulin treatment persistence varies among payersA study from Walgreens provides a benchmark of basal insulin treatment persistence across different payers in the United States.